key: cord-0979266-dn8aitfo
authors: Kluger, Malte A.; Czogalla, Jan; Schmidt‐Lauber, Christian; Peine, Sven; Schmiedel, Stefan; Bangert, Katrin; Kluge, Stefan; Huber, Samuel; Puelles, Victor G.; Fischer, Lutz; Huber, Tobias B.; Grahammer, Florian
title: Convalescent plasma treatment for early post‐kidney transplant acquired COVID‐19
date: 2021-07-20
journal: Transpl Infect Dis
DOI: 10.1111/tid.13685
sha: 1cbc5c55bea1f98d23bcee4339528b5e7f624144
doc_id: 979266
cord_uid: dn8aitfo

nan

A 69-year-old diabetic patient developed severe COVID-19associated pneumonia 6 days after KTx (DBD, ESP). IS consisted of induction with Basiliximab and IV steroids, and maintenance with tacrolimus (TAC), mycophenolic-acid (MPA) and rapidly weaned steroids. TAC/MPA were reduced, followed by three doses of con- 

Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and lifethreatening COVID-19: a randomized clinical trial

Multiorgan and renal tropism of SARS-CoV-2

COVID-19-associated nephritis: early warning for disease severity and complications?

Treatment of COVID-19 patients with convalescent plasma

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma